A case of complete recovery in a hypereosinophilic dermatitis patient with dupilumab

ConclusionIn conclusion, we report a new application of dupilumab in HED patients, especially with  difficulties in reducing the glucocorticoid dose.
Source: Inflammation Research - Category: Research Source Type: research